![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: MKNK1 |
Gene summary for MKNK1 |
![]() |
Gene information | Species | Human | Gene symbol | MKNK1 | Gene ID | 8569 |
Gene name | MAPK interacting serine/threonine kinase 1 | |
Gene Alias | MNK1 | |
Cytomap | 1p33 | |
Gene Type | protein-coding | GO ID | GO:0006412 | UniProtAcc | Q9BUB5 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
8569 | MKNK1 | C08 | Human | Oral cavity | OSCC | 5.72e-06 | 3.04e-01 | 0.1919 |
8569 | MKNK1 | C09 | Human | Oral cavity | OSCC | 1.64e-02 | 1.81e-01 | 0.1431 |
8569 | MKNK1 | LN22 | Human | Oral cavity | OSCC | 1.29e-04 | 8.80e-01 | 0.1733 |
8569 | MKNK1 | LP15 | Human | Oral cavity | LP | 7.47e-07 | 1.13e+00 | 0.2174 |
8569 | MKNK1 | SYSMH1 | Human | Oral cavity | OSCC | 2.73e-24 | 6.94e-01 | 0.1127 |
8569 | MKNK1 | SYSMH2 | Human | Oral cavity | OSCC | 5.26e-08 | 3.85e-01 | 0.2326 |
8569 | MKNK1 | SYSMH3 | Human | Oral cavity | OSCC | 3.99e-21 | 5.42e-01 | 0.2442 |
8569 | MKNK1 | P1_cSCC | Human | Skin | cSCC | 2.59e-17 | 6.69e-01 | 0.0292 |
8569 | MKNK1 | P2_cSCC | Human | Skin | cSCC | 3.29e-04 | 3.01e-01 | -0.024 |
8569 | MKNK1 | P4_cSCC | Human | Skin | cSCC | 3.14e-06 | 3.58e-01 | -0.00290000000000005 |
8569 | MKNK1 | P10_cSCC | Human | Skin | cSCC | 2.70e-13 | 5.66e-01 | 0.1017 |
Page: 1 2 3 4 5 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:0006417111 | Esophagus | ESCC | regulation of translation | 304/8552 | 468/18723 | 1.53e-17 | 1.33e-15 | 304 |
GO:004677710 | Esophagus | ESCC | protein autophosphorylation | 138/8552 | 227/18723 | 2.98e-06 | 3.38e-05 | 138 |
GO:00182099 | Esophagus | ESCC | peptidyl-serine modification | 196/8552 | 338/18723 | 3.07e-06 | 3.47e-05 | 196 |
GO:001810515 | Esophagus | ESCC | peptidyl-serine phosphorylation | 184/8552 | 315/18723 | 3.22e-06 | 3.61e-05 | 184 |
GO:000641722 | Liver | HCC | regulation of translation | 287/7958 | 468/18723 | 8.79e-17 | 8.08e-15 | 287 |
GO:001810511 | Liver | HCC | peptidyl-serine phosphorylation | 169/7958 | 315/18723 | 3.86e-05 | 3.81e-04 | 169 |
GO:001820911 | Liver | HCC | peptidyl-serine modification | 177/7958 | 338/18723 | 1.45e-04 | 1.17e-03 | 177 |
GO:00467775 | Liver | HCC | protein autophosphorylation | 123/7958 | 227/18723 | 2.40e-04 | 1.80e-03 | 123 |
GO:000641720 | Oral cavity | OSCC | regulation of translation | 274/7305 | 468/18723 | 4.39e-18 | 4.63e-16 | 274 |
GO:00182098 | Oral cavity | OSCC | peptidyl-serine modification | 175/7305 | 338/18723 | 1.09e-06 | 1.46e-05 | 175 |
GO:001810510 | Oral cavity | OSCC | peptidyl-serine phosphorylation | 164/7305 | 315/18723 | 1.51e-06 | 1.99e-05 | 164 |
GO:00467779 | Oral cavity | OSCC | protein autophosphorylation | 123/7305 | 227/18723 | 2.31e-06 | 2.93e-05 | 123 |
GO:0006417110 | Oral cavity | LP | regulation of translation | 175/4623 | 468/18723 | 4.49e-10 | 2.22e-08 | 175 |
GO:000641729 | Skin | cSCC | regulation of translation | 226/4864 | 468/18723 | 8.78e-26 | 2.62e-23 | 226 |
GO:004677715 | Skin | cSCC | protein autophosphorylation | 84/4864 | 227/18723 | 1.53e-04 | 1.35e-03 | 84 |
GO:001820923 | Skin | cSCC | peptidyl-serine modification | 108/4864 | 338/18723 | 7.73e-03 | 3.60e-02 | 108 |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
hsa0406629 | Esophagus | ESCC | HIF-1 signaling pathway | 75/4205 | 109/8465 | 3.66e-05 | 1.68e-04 | 8.60e-05 | 75 |
hsa049109 | Esophagus | ESCC | Insulin signaling pathway | 89/4205 | 137/8465 | 1.97e-04 | 7.32e-04 | 3.75e-04 | 89 |
hsa04066113 | Esophagus | ESCC | HIF-1 signaling pathway | 75/4205 | 109/8465 | 3.66e-05 | 1.68e-04 | 8.60e-05 | 75 |
hsa0491014 | Esophagus | ESCC | Insulin signaling pathway | 89/4205 | 137/8465 | 1.97e-04 | 7.32e-04 | 3.75e-04 | 89 |
hsa0491041 | Liver | HCC | Insulin signaling pathway | 95/4020 | 137/8465 | 1.53e-07 | 1.97e-06 | 1.10e-06 | 95 |
hsa0406622 | Liver | HCC | HIF-1 signaling pathway | 70/4020 | 109/8465 | 2.96e-04 | 1.36e-03 | 7.57e-04 | 70 |
hsa0491051 | Liver | HCC | Insulin signaling pathway | 95/4020 | 137/8465 | 1.53e-07 | 1.97e-06 | 1.10e-06 | 95 |
hsa0406632 | Liver | HCC | HIF-1 signaling pathway | 70/4020 | 109/8465 | 2.96e-04 | 1.36e-03 | 7.57e-04 | 70 |
hsa049108 | Oral cavity | OSCC | Insulin signaling pathway | 83/3704 | 137/8465 | 4.83e-05 | 2.00e-04 | 1.02e-04 | 83 |
hsa0406627 | Oral cavity | OSCC | HIF-1 signaling pathway | 68/3704 | 109/8465 | 6.30e-05 | 2.48e-04 | 1.26e-04 | 68 |
hsa0401014 | Oral cavity | OSCC | MAPK signaling pathway | 165/3704 | 302/8465 | 7.11e-05 | 2.74e-04 | 1.40e-04 | 165 |
hsa0491013 | Oral cavity | OSCC | Insulin signaling pathway | 83/3704 | 137/8465 | 4.83e-05 | 2.00e-04 | 1.02e-04 | 83 |
hsa04066112 | Oral cavity | OSCC | HIF-1 signaling pathway | 68/3704 | 109/8465 | 6.30e-05 | 2.48e-04 | 1.26e-04 | 68 |
hsa0401015 | Oral cavity | OSCC | MAPK signaling pathway | 165/3704 | 302/8465 | 7.11e-05 | 2.74e-04 | 1.40e-04 | 165 |
hsa0406628 | Oral cavity | LP | HIF-1 signaling pathway | 42/2418 | 109/8465 | 1.52e-02 | 4.75e-02 | 3.06e-02 | 42 |
hsa0406636 | Oral cavity | LP | HIF-1 signaling pathway | 42/2418 | 109/8465 | 1.52e-02 | 4.75e-02 | 3.06e-02 | 42 |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
MKNK1 | SNV | Missense_Mutation | novel | c.139N>G | p.Met47Val | p.M47V | Q9BUB5 | protein_coding | tolerated(1) | benign(0) | TCGA-A8-A09Z-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
MKNK1 | SNV | Missense_Mutation | novel | c.94N>T | p.Arg32Trp | p.R32W | Q9BUB5 | protein_coding | deleterious(0) | probably_damaging(0.945) | TCGA-BH-A1FU-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Unknown | Unknown | PD |
MKNK1 | SNV | Missense_Mutation | novel | c.13N>G | p.Gln5Glu | p.Q5E | Q9BUB5 | protein_coding | tolerated_low_confidence(0.12) | benign(0.011) | TCGA-DR-A0ZM-01 | Cervix | cervical & endocervical cancer | Female | <65 | III/IV | Unspecific | Cisplatin | SD |
MKNK1 | SNV | Missense_Mutation | novel | c.224N>G | p.Tyr75Cys | p.Y75C | Q9BUB5 | protein_coding | deleterious(0.03) | probably_damaging(0.994) | TCGA-A6-2672-01 | Colorectum | colon adenocarcinoma | Female | >=65 | III/IV | Unknown | Unknown | SD |
MKNK1 | SNV | Missense_Mutation | novel | c.1201N>C | p.Phe401Leu | p.F401L | Q9BUB5 | protein_coding | tolerated(0.06) | probably_damaging(0.998) | TCGA-CM-6171-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
MKNK1 | SNV | Missense_Mutation | novel | c.1229G>A | p.Arg410His | p.R410H | Q9BUB5 | protein_coding | deleterious(0) | probably_damaging(0.999) | TCGA-WS-AB45-01 | Colorectum | colon adenocarcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
MKNK1 | SNV | Missense_Mutation | novel | c.227C>A | p.Ala76Asp | p.A76D | Q9BUB5 | protein_coding | deleterious(0) | probably_damaging(0.999) | TCGA-EI-6507-01 | Colorectum | rectum adenocarcinoma | Male | <65 | I/II | Unknown | Unknown | SD |
MKNK1 | SNV | Missense_Mutation | rs200209678 | c.1327N>T | p.Arg443Cys | p.R443C | Q9BUB5 | protein_coding | deleterious(0) | possibly_damaging(0.732) | TCGA-A5-A0G1-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
MKNK1 | SNV | Missense_Mutation | novel | c.464N>T | p.Ala155Val | p.A155V | Q9BUB5 | protein_coding | deleterious(0.01) | probably_damaging(0.967) | TCGA-A5-A0G1-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
MKNK1 | SNV | Missense_Mutation | novel | c.1014N>T | p.Lys338Asn | p.K338N | Q9BUB5 | protein_coding | deleterious(0.04) | possibly_damaging(0.826) | TCGA-A5-A7WJ-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
Page: 1 2 3 4 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
8569 | MKNK1 | SERINE THREONINE KINASE, CLINICALLY ACTIONABLE, DRUGGABLE GENOME, KINASE, ENZYME | CGP-57380 | CHEMBL1240885 | 25800647 | |
8569 | MKNK1 | SERINE THREONINE KINASE, CLINICALLY ACTIONABLE, DRUGGABLE GENOME, KINASE, ENZYME | EFT508 | TOMIVOSERTIB | ||
8569 | MKNK1 | SERINE THREONINE KINASE, CLINICALLY ACTIONABLE, DRUGGABLE GENOME, KINASE, ENZYME | inhibitor | 178101606 | DORSOMORPHIN | |
8569 | MKNK1 | SERINE THREONINE KINASE, CLINICALLY ACTIONABLE, DRUGGABLE GENOME, KINASE, ENZYME | inhibitor | 178102632 | ||
8569 | MKNK1 | SERINE THREONINE KINASE, CLINICALLY ACTIONABLE, DRUGGABLE GENOME, KINASE, ENZYME | inhibitor | 381118877 | TOMIVOSERTIB |
Page: 1 |